Health Care sector at a glance
Pharma, biotech, medical devices, health insurers and hospitals. Approvals and patents play a big role.
Automated stock and chart analysis, not investment advice – the decision and the risk are yours. Risk notice and investment advice
What belongs to the Health Care sector?
The health care sector covers pharmaceutical companies, biotechnology firms, makers of medical devices and lab equipment, health insurers, hospital operators and drug wholesalers. Demand depends little on the economy, because treatments are rarely postponed. What shapes the sector instead are patents, approvals and trial results: when protection for a top-selling drug expires, a large part of revenue can disappear within a few years. Biotechnology firms often run losses for a long time before a product is approved. Insurers and hospital operators work with low margins but high revenue. Political decisions on drug prices and reimbursement affect the whole sector.
The sector in numbers
- Stocks covered
- 26
- Rank Week
- 4 of 11
- Rank Month
- 4 of 11
- Above 200-day line
- 69%
- (18 of 26 symbols)
Rank among all sectors by average price change (1 = strongest). You see the numbers after logging in.
Sector key figures (median)
- Revenue growth per year (5 years)
- +8.5%
- from 25 stocks
- Revenue growth per year (3 years)
- +5.6%
- from 25 stocks
- Earnings growth per year (5 years)
- +5.5%
- from 20 stocks
- Net margin
- 13.9%
- from 26 stocks
- Debt to equity
- 0.66
- from 19 stocks
- Payout ratio
- 55.6%
- from 16 stocks
Median = middle value of the sector: half of the stocks are above it, half below. Only business figures from SEC filings, no price; a median requires at least 5 stocks with data. As of Nov 22, 2026.
Strongest quality checks
The stocks in the sector with the largest share of criteria met in the four quality checks (quality, growth, dividend, financial strength) – from business figures, without price. A fact, not a rating of the stock.
- Intuitive Surgical (ISRG) 19 of 20 criteria met
- Stryker Corporation (SYK) 26 of 28 criteria met
- Lilly (Eli) (LLY) 25 of 27 criteria met
- Merck & Co. (MRK) 24 of 26 criteria met
- Vertex Pharmaceuticals (VRTX) 18 of 20 criteria met
All symbols in this sector
| Symbol | Criteria met |
|---|---|
| Abbott Laboratories ABT | 17/21 |
| AbbVie ABBV | 17/27 |
| Amgen AMGN | 24/28 |
| Bristol Myers Squibb BMY | 18/26 |
| Cigna CI | 8/11 |
| CVS Health CVS | 18/27 |
| Danaher Corporation DHR | 14/21 |
| Elevance Health ELV | 22/27 |
| Gilead Sciences GILD | 24/28 |
| HCA Healthcare HCA | 15/18 |
| ImmunityBio IBRX | 5/17 |
| Intuitive Surgical ISRG | 19/20 |
| Iovance Biotherapeutics IOVA | 1/8 |
| Johnson & Johnson JNJ | 23/26 |
| Lilly (Eli) LLY | 25/27 |
| McKesson Corporation MCK | 17/26 |
| Medtronic MDT | 24/28 |
| Merck & Co. MRK | 24/26 |
| Moderna MRNA | 7/20 |
| Novavax NVAX | 4/13 |
| Pfizer PFE | 17/26 |
| Regeneron Pharmaceuticals REGN | 17/20 |
| Stryker Corporation SYK | 26/28 |
| Thermo Fisher Scientific TMO | 23/27 |
| UnitedHealth Group UNH | 19/27 |
| Vertex Pharmaceuticals VRTX | 18/20 |
Figures as of Nov 22, 2026. Past performance, not a forecast.